Spyre Therapeutics Statistics

Total Valuation

SYRE has a market cap or net worth of $763.69 million. The enterprise value is $160.60 million.

Market Cap	763.69M
Enterprise Value	160.60M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

SYRE has 60.28 million shares outstanding. The number of shares has increased by 581.85% in one year.

Current Share Class	60.28M
Shares Outstanding	60.28M
Shares Change (YoY)	+581.85%
Shares Change (QoQ)	+8.59%
Owned by Insiders (%)	8.74%
Owned by Institutions (%)	87.26%
Float	46.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.11
P/TBV Ratio	2.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.26

Current Ratio	11.26
Quick Ratio	11.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -59.28% and return on invested capital (ROIC) is -37.15%.

Return on Equity (ROE)	-59.28%
Return on Assets (ROA)	-27.43%
Return on Invested Capital (ROIC)	-37.15%
Return on Capital Employed (ROCE)	-37.62%
Revenue Per Employee	n/a
Profits Per Employee	-$2.30M
Employee Count	65
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, SYRE has paid $51,000 in taxes.

Income Tax	51,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.12% in the last 52 weeks. The beta is 3.06, so SYRE's price volatility has been higher than the market average.

Beta (5Y)	3.06
52-Week Price Change	-65.12%
50-Day Moving Average	18.05
200-Day Moving Average	25.27
Relative Strength Index (RSI)	36.18
Average Volume (20 Days)	899,502

Short Selling Information

The latest short interest is 11.36 million, so 18.84% of the outstanding shares have been sold short.

Short Interest	11.36M
Short Previous Month	10.77M
Short % of Shares Out	18.84%
Short % of Float	24.36%
Short Ratio (days to cover)	17.05

Income Statement

Revenue	n/a
Gross Profit	-162.79M
Operating Income	-208.57M
Pretax Income	-185.95M
Net Income	-149.56M
EBITDA	-207.82M
EBIT	-208.57M
Earnings Per Share (EPS)	-$3.18

Full Income Statement

Balance Sheet

The company has $603.09 million in cash and n/a in debt, giving a net cash position of $603.09 million or $10.01 per share.

Cash & Cash Equivalents	603.09M
Total Debt	n/a
Net Cash	603.09M
Net Cash Per Share	$10.01
Equity (Book Value)	517.80M
Book Value Per Share	6.01
Working Capital	554.41M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-157.41M
Capital Expenditures	n/a
Free Cash Flow	-157.41M
FCF Per Share	-$2.61

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SYRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-581.85%
Shareholder Yield	n/a
Earnings Yield	-19.58%
FCF Yield	-20.61%

Analyst Forecast

The average price target for SYRE is $50.00, which is 295.26% higher than the current price. The consensus rating is "Buy".

Price Target	$50.00
Price Target Difference	295.26%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	8.65%

Stock Forecasts

Stock Splits

The last stock split was on September 8, 2023. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Sep 8, 2023
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1